Annandale Capital, LLC Pfizer Inc Transaction History

Annandale Capital, LLC

$543 Million
Q1 2024

A detailed history of Annandale Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Annandale Capital, LLC holds 18,568 shares of PFE stock, worth $516,747. This represents 0.09% of its overall portfolio holdings.

Number of Shares

18,568

Previous 8,643 114.83%

Holding current value

$516,747

Previous $249,000 106.83%

% of portfolio

0.09%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $256,958 - $295,070	9,925 Added 114.83%	18,568 $515,000
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $54,533 - $70,832	2,087 Added 31.83%	8,643 $249,000
Q3 2023 Nov 15, 2023	SELL	$32.09 - $37.51 $46,498 - $54,351	-1,449 Reduced 18.1%	6,556 $217,000
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $68,086 - $78,774	1,885 Added 30.8%	8,005 $294,000
Q1 2023 May 15, 2023	SELL	$39.39 - $51.28 $4,017 - $5,230	-102 Reduced 1.64%	6,120 $250,000

Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $7,807 - $10,191	-187 Reduced 2.92%	6,222 $319,000
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $87 - $106	2 Added 0.03%	6,409 $280,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $44,901 - $53,239	965 Added 17.73%	6,407 $336,000
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $216,168 - $267,860	-4,725 Reduced 46.47%	5,442 $282,000
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $54,790 - $81,217	-1,326 Reduced 11.54%	10,167 $600,000
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $11,853 - $15,226	-302 Reduced 2.56%	11,493 $494,000
Q2 2021 Aug 17, 2021	BUY	$35.91 - $40.68 $39,572 - $44,829	1,102 Added 10.31%	11,795 $462,000
Q1 2021 May 14, 2021	SELL	$33.49 - $37.77 $9,477 - $10,688	-283 Reduced 2.58%	10,693 $387,000
Q4 2020 Feb 09, 2021	BUY	$33.47 - $42.56 $367,366 - $467,138	10,976 New	10,976 $404,000

Others Institutions Holding PFE

# of Institutions

3,158

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Annandale Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Annandale Capital, LLC with notifications on news.

Account

Annandale Capital, LLC Pfizer Inc Transaction History